118 related articles for article (PubMed ID: 37264873)
21. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
23. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway.
Ao R; Guan L; Wang Y; Wang JN
J Cell Biochem; 2018 Jun; 119(6):4420-4434. PubMed ID: 29143985
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
26. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
27. Piperine Inhibits Cell Proliferation and Induces Apoptosis of Human Gastric Cancer Cells by Downregulating Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway.
Chen H; Sheng H; Zhao Y; Zhu G
Med Sci Monit; 2020 Dec; 26():e928403. PubMed ID: 33382670
[TBL] [Abstract][Full Text] [Related]
28. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
29. PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.
Yun SM; Yoon K; Lee S; Kim E; Kong SH; Choe J; Kang JM; Han TS; Kim P; Choi Y; Jho S; Yoo H; Bhak J; Yang HK; Kim SJ
Oncogene; 2014 Nov; 33(46):5341-7. PubMed ID: 24276243
[TBL] [Abstract][Full Text] [Related]
30. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
31. The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway.
Zhu L; Li Z; Yu X; Ruan Y; Shen Y; Shao Y; Zhang X; Ye G; Guo J
Stem Cell Res Ther; 2021 Jul; 12(1):418. PubMed ID: 34294122
[TBL] [Abstract][Full Text] [Related]
32. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
33. Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies.
Cooper AM; Nutter CA; Kuyumcu-Martinez MN; Wright CW
Mol Cell Biol; 2022 May; 42(5):e0050321. PubMed ID: 35404107
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer.
Ren F; Zhao Q; Liu B; Sun X; Tang Y; Huang H; Mei L; Yu Y; Mo H; Dong H; Zheng P; Mi Y
J Cell Physiol; 2020 Mar; 235(3):2738-2752. PubMed ID: 31498430
[TBL] [Abstract][Full Text] [Related]
35. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
[TBL] [Abstract][Full Text] [Related]
36. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
Jbara A; Lin KT; Stossel C; Siegfried Z; Shqerat H; Amar-Schwartz A; Elyada E; Mogilevsky M; Raitses-Gurevich M; Johnson JL; Yaron TM; Ovadia O; Jang GH; Danan-Gotthold M; Cantley LC; Levanon EY; Gallinger S; Krainer AR; Golan T; Karni R
Nature; 2023 May; 617(7959):147-153. PubMed ID: 36949200
[TBL] [Abstract][Full Text] [Related]
37. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
[TBL] [Abstract][Full Text] [Related]
38. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
39. ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly.
Wu S; Chen M; Huang J; Zhang F; Lv Z; Jia Y; Cui YZ; Sun LZ; Wang Y; Tang Y; Verhoeft KR; Li Y; Qin Y; Lin X; Guan XY; Lam KO
Cancer Res; 2021 Feb; 81(4):986-1000. PubMed ID: 33310726
[TBL] [Abstract][Full Text] [Related]
40. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]